北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第二临床医学院  > 期刊论文
学科主题: 临床医学
题名:
Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis
作者: Liu, Yanying1; Mu, Rong1; Wang, Shiyao1; Long, Li1; Liu, Xia1; Li, Ru1; Sun, Jian1; Guo, Jianping1; Zhang, Xiaoping1; Guo, Jing1; Yu, Ping1; Li, Chunlei1; Liu, Xiangyuan2; Huang, Zhenyu3; Wang, Dapeng3; Li, Hu4; Gu, Zhifeng5; Liu, Bing6; Li, Zhanguo1
刊名: ARTHRITIS RESEARCH & THERAPY
发表日期: 2010
DOI: 10.1186/ar3187
卷: 12, 期:6
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Rheumatology
研究领域[WOS]: Rheumatology
关键词[WOS]: COLLAGEN-INDUCED ARTHRITIS ; REGULATORY T-CELLS ; FIBROBLAST-LIKE SYNOVIOCYTES ; BONE-MARROW ; BIOLOGICS-REGISTER ; TNF-ALPHA ; RESPONSES ; DISEASE ; AUTOIMMUNE ; PROLIFERATION
英文摘要:

Introduction: Rheumatoid arthritis (RA) is a T-cell-mediated systemic autoimmune disease, characterized by synovium inflammation and articular destruction. Bone marrow mesenchymal stem cells (MSCs) could be effective in the treatment of several autoimmune diseases. However, there has been thus far no report on umbilical cord (UC)-MSCs in the treatment of RA. Here, potential immunosuppressive effects of human UC-MSCs in RA were evaluated.

Methods: The effects of UC-MSCs on the responses of fibroblast-like synoviocytes (FLSs) and T cells in RA patients were explored. The possible molecular mechanism mediating this immunosuppressive effect of UC-MSCs was explored by addition of inhibitors to indoleamine 2,3-dioxygenase (IDO), Nitric oxide (NO), prostaglandin E2 (PGE2), transforming growth factor beta 1 (TGF-beta 1) and interleukin 10 (IL-10). The therapeutic effects of systemic infusion of human UC-MSCs on collagen-induced arthritis (CIA) in a mouse model were explored.

Results: In vitro, UC-MSCs were capable of inhibiting proliferation of FLSs from RA patients, via IL-10, IDO and TGF-beta 1. Furthermore, the invasive behavior and IL-6 secretion of FLSs were also significantly suppressed. On the other hand, UC-MSCs induced hyporesponsiveness of T cells mediated by PGE2, TGF-beta 1 and NO and UC-MSCs could promote the expansion of CD4(+) Foxp3(+) regulatory T cells from RA patients. More importantly, systemic infusion of human UC-MSCs reduced the severity of CIA in a mouse model. Consistently, there were reduced levels of proinflammatory cytokines and chemokines (TNF-alpha, IL-6 and monocyte chemoattractant protein-1) and increased levels of the anti-inflammatory/regulatory cytokine (IL-10) in sera of UC-MSCs treated mice. Moreover, such treatment shifted Th1/Th2 type responses and induced Tregs in CIA.

Conclusions: In conclusion, human UC-MSCs suppressed the various inflammatory effects of FLSs and T cells of RA in vitro, and attenuated the development of CIA in vivo, strongly suggesting that UC-MSCs might be a therapeutic strategy in RA. In addition, the immunosuppressive activitiy of UC-MSCs could be prolonged by the participation of Tregs.

语种: 英语
所属项目编号: 2010 CB 529100 ; 2008BAI59B01 ; 30972710 ; RDB 2009-05
项目资助者: National Basic Research Program of China ; Key Projects in the National Science &amp ; Technology Pillar Program in the Eleventh Five-year Plan Period ; National Sciences Foundation of China ; Peking University People&prime ; s Hospital
WOS记录号: WOS:000287517000020
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/52798
Appears in Collections:北京大学第二临床医学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100044, Peoples R China
2.Peking Univ, Hosp 3, Dept Rheumatol & Immunol, Beijing 100191, Peoples R China
3.Peking Univ, Peoples Hosp, Dept Gynecol & Obstet, Beijing 100044, Peoples R China
4.Peking Univ, Peoples Hosp, Arthrit Clin & Res Ctr, Beijing 100044, Peoples R China
5.Nantong Univ, Affiliated Hosp, Dept Rheumatol, Nantong 226001, Peoples R China
6.Acad Mil Med Sci, Affiliated Hosp, Lab Oncol, Beijing 100071, Peoples R China

Recommended Citation:
Liu, Yanying,Mu, Rong,Wang, Shiyao,et al. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis[J]. ARTHRITIS RESEARCH & THERAPY,2010,12(6).
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Liu, Yanying]'s Articles
[Mu, Rong]'s Articles
[Wang, Shiyao]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Liu, Yanying]‘s Articles
[Mu, Rong]‘s Articles
[Wang, Shiyao]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace